These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 723151)

  • 1. Resistance to parathyroid hormone in renal failure: role of vitamin D metabolites.
    Somerville PJ; Kaye M
    Kidney Int; 1978 Sep; 14(3):245-54. PubMed ID: 723151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Skeletal resistance to the calcemic action of parathyroid hormone in uremia: role of 1,25 (OH)2 D3.
    Massry SG; Stein R; Garty J; Arieff AI; Coburn JW; Norman AW; Friedler RM
    Kidney Int; 1976 Jun; 9(6):467-74. PubMed ID: 940279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of skeletal resistance to parathyroid hormone in uremia by vitamin D metabolites: evidence for the requirement of 1,25(OH)2D3 and 24,25(OH)2D3.
    Massry SG; Tuma S; Dua S; Goldstein DA
    J Lab Clin Med; 1979 Jul; 94(1):152-7. PubMed ID: 469372
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects in vivo of vitamin D metabolites and 17 beta-estradiol on parathyroid hormone-dependent formation of adenosine 3',5'-monophosphate in rat bone.
    Marcus R; Orner FB; Brickman AS
    Endocrinology; 1980 Nov; 107(5):1593-9. PubMed ID: 6253269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction of the parathyroid and 1,25-dihydroxyvitamin D3 in the control of renal 25-hydroxyvitamin D3 metabolism.
    Omdahl JL
    J Biol Chem; 1978 Dec; 253(23):8474-8. PubMed ID: 711762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Vitamin D metabolism in kidney insufficiency: disorders of an endocrine regulatory zone].
    Ritz E; Kreusser W; Boland R; Bommer J
    Klin Wochenschr; 1979 Oct; 57(19):1053-9. PubMed ID: 392179
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of growth hormone on the metabolism of 25-hydroxycholecalciferol in hypophysectomized rats on a diet without vitamin D and low in calcium.
    Pavlovitch H; Fontaine O; Balsan S
    J Endocrinol; 1978 Dec; 79(3):277-81. PubMed ID: 744925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolism of 25 hydroxycholecalciferol II. Chronic kidney failure in the vitamin D deficient rat].
    Gruson M; Miravet L
    C R Seances Soc Biol Fil; 1974; 168(8-9):948-52. PubMed ID: 4282340
    [No Abstract]   [Full Text] [Related]  

  • 10. The effect of decreased renal function with and without reduction in renal mass on 1,25-dihydroxycholecalciferol production in rats.
    van Stone JC; Frank DE; Bradford WR
    J Lab Clin Med; 1977 Jun; 89(6):1168-74. PubMed ID: 864300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of 24,25(OH)2D3 on the calcemic effect of 1,25(OH)2D in rats with chronic renal failure is parathyroid hormone dependent.
    Rubinger D; Krause Y; Krause I; Popovtzer MM
    Proc Soc Exp Biol Med; 1990 Oct; 195(1):13-7. PubMed ID: 2399255
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolism of vitamin D: current status.
    DeLuca HF
    Am J Clin Nutr; 1976 Nov; 29(11):1258-70. PubMed ID: 187053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitamin D metabolites do not alter parathyroid hormone secretion acutely.
    Magliola L; Anast CS; Forte LR
    Bone Miner; 1986 Dec; 1(6):495-505. PubMed ID: 3509783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to the phosphaturic and calcemic actions of parathyroid hormone during phosphate depletion. Prevention by 1,25-dihydroxyvitamin D3.
    Gloor HJ; Bonjour JP; Caverzasio J; Fleisch H
    J Clin Invest; 1979 Mar; 63(3):371-7. PubMed ID: 34630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of a lack of change in serum 1 alpha,25-dihydroxyvitamin D in response to parathyroid extract in pseudohypoparathyroidism.
    Lambert PW; Hollis BW; Bell NH; Epstein S
    J Clin Invest; 1980 Oct; 66(4):782-91. PubMed ID: 7419719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminoaciduria in chronic renal failure--its relationship to vitamin D and parathyroid status.
    Phillips ME; Havard J; Otterud B
    Am J Clin Nutr; 1980 Jul; 33(7):1541-5. PubMed ID: 6893104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duodenal active transport of calcium and phosphate in vitamin D-deficient rats: effects of nephrectomy, Cestrum diurnum, and 1alpha,25-dihydroxyvitamin D3.
    Walling MW; Kimberg DV; Wasserman RH; Feinberg RR
    Endocrinology; 1976 May; 98(5):1130-4. PubMed ID: 1261508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biologic effects of 1,25-dihydroxycholecalciferol (a highly active vitamin D metabolite) in acutely uremic rats.
    Wong RG; Norman AW; Reddy CR; Coburn JW
    J Clin Invest; 1972 May; 51(5):1287-91. PubMed ID: 4341503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D: the discovery of its metabolites and their therapeutic applications.
    Beale MG; Chan JC; Oldham SB; Deluca HF
    Pediatrics; 1976 May; 57(5):729-41. PubMed ID: 181725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abnormal expression and regulation of vitamin D receptor in experimental uremia.
    Szabó A; Ritz E; Schmidt-Gayk H; Reichel H
    Nephron; 1996; 73(4):619-28. PubMed ID: 8856261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.